Live Breaking News & Updates on Systematix Infotech

Stay updated with breaking news from Systematix infotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

mrf: Up to 31% downside: 5 stocks to avoid right now

Investors should stay away from the companies that have been snubbed by analysts as these have a higher probability of generating losses. ....

Yes Bank , Tata Elxsi , India Cements , Exchange Rate , Bull Bear , Bharti Airtel ,

One-way street! As Nifty defies gravity, equity investors risk turbulence

While the headline valuation may not look very expensive, it could be misleading due to the large contribution of banks to overall profits of Nifty. A sectoral break-up of net profits of Nifty50 index across shows that the contribution of banks has gone up from 21% in 2022 to 27% in 2023. ....

Vijay Kedia , Sanjeev Prasad , Vikash Jain , Dhananjay Sinha , Systematix Institutional Research , Kotak Institutional , Systematix Institutional , Stock Market Rally , Stock Market Latest News , Stock Market News , Nifty Rally , Sensex Nifty News ,

upl: Bet on companies that manage debt well: 5 stocks with up to 33% upside potential

The companies that have improved their debt repayment capability or have reduced their debt levels can be good picks as interest rates will continue to remain high. ....

Tata Steel , Tata Motors , Lower Earnings , Jsw Steel , Interest Rates , Fortis Healthcare , Capital Expenditure ,

mankind pharma stock price target: Mankind Pharma draws rush of buy calls on 57% jump since IPO

Investors are scrambling to purchase shares in drug and condom maker, Mankind Pharma Ltd., which has had the most analyst coverage of any new Indian stock in 12 years after its highly successful May IPO. The shares have surged by 57% since being listed, driving its market value above $8bn. The firm has attracted nine buy ratings and one hold. While the majority of analysts recommend buying shares, the consensus price target is already 10% below the current value due to its stellar run. ....

Vishal Avinash Manchanda , Shrikant Akolkar , Mankind Pharma Ltd , Systematix Group , Mankind Pharma , Asian Markets Securities , Mankind Pharma Stock Price Target , Mankind Pharma Share Price , Mankind Pharma Stock Price , Mankind Pharma Ipo , Mankind Pharma Stock Outlook ,